Opko Health (OPK) has great potential as testing becomes a necessity
Opko Health Inc (OPK) currently trades at $1.33 and has fallen by 3% in the past 24 hours. The ongoing struggle to expand local testing has been criticized as an early misstep in the government’s response to the outbreak, which has killed more than 3,300 people around the globe, including 11 in the United States. U.S. health officials said on Thursday they expect to deliver enough coronavirus tests to public laboratories this week to test about 400,000 people.
Based on this information, investorsQ rates this stock 5 out of 10. We give it this rating because OPKO said on Thursday they would be able to begin testing for coronavirus from next week, as the U.S. government ramps up efforts to increase diagnostic capabilities. The high forecast for Opko Health Inc is $6.00 and the low is $3.00. Notably, the company’s market cap is $886.18 million with a 52 week high of $2.91 and a 52 week low of $1.30.